Gestational Trophoblastic Tumor Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Conditions: Gestational Trophoblastic Neoplasia; Choriocarcinoma; Placental Site Trophoblastic Tumor; Epithelioid Trophoblastic TumorInterventions: Drug: TRC105; Drug: BevacizumabSponsor: Tracon Pharmaceuticals Inc.Not yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2016 Category: Research Source Type: clinical trials

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Condition: Gestational Trophoblastic NeoplasmsInterventions: Drug: Etoposide; Drug: actinomycin D; Drug: methotrexate; Drug: vincristine; Drug: cyclophosphamide; Drug: Paclitaxel; Drug: Cisplatin; Drug: CarboplatinSponsors: Weiguo Lv; First Affiliated Hospital of Zhongshan Medical University; Shandong University; Huazhong University of Science and TechnologyNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2015 Category: Research Source Type: clinical trials